Seung Up Kim Selected Research

acarboxyprothrombin (PIVKA)

1/2021	Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization.
1/2020	Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization.
1/2020	Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
8/2019	Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma.
1/2019	Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection.
1/2016	Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
2/2014	Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.
1/2013	Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
7/2012	Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
1/2012	Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seung Up Kim Research Topics

Disease

101	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 12/2010
76	Chronic Hepatitis B 01/2022 - 01/2008
45	Fibrosis (Cirrhosis) 10/2022 - 08/2010
42	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 03/2009
31	Neoplasms (Cancer) 05/2022 - 02/2008
13	Infections 11/2021 - 12/2011
10	Liver Diseases (Liver Disease) 10/2022 - 07/2009
10	Non-alcoholic Fatty Liver Disease 01/2022 - 08/2015
9	Hypertension (High Blood Pressure) 03/2022 - 11/2015
8	Hepatitis B 01/2022 - 12/2010
7	Thrombosis (Thrombus) 05/2022 - 07/2012
7	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2014
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2010
6	Chronic Hepatitis C 01/2021 - 01/2013
5	Disease Progression 03/2022 - 01/2008
5	Neoplasm Metastasis (Metastasis) 07/2013 - 12/2008
4	Fatty Liver 10/2022 - 12/2020
4	Insulin Resistance 06/2021 - 01/2015
4	Hepatitis 01/2019 - 07/2009
4	Diabetes Mellitus 11/2017 - 11/2015
3	Sarcopenia 01/2022 - 01/2020
3	Obesity 06/2021 - 08/2015
3	Hemorrhage 01/2021 - 02/2015
3	End Stage Liver Disease 01/2021 - 01/2014
3	Dyslipidemias (Dyslipidemia) 12/2020 - 01/2017
3	Ascites 09/2019 - 01/2016
3	Hypoxia (Hypoxemia) 01/2016 - 01/2014
2	Diarrhea 03/2022 - 01/2020
2	Body Weight (Weight, Body) 01/2022 - 02/2015
2	Viremia 01/2022 - 01/2021
2	Leukopenia 10/2021 - 07/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2016
2	Rupture 06/2019 - 08/2014
2	Hyperbilirubinemia 01/2018 - 07/2010
2	Virus Diseases (Viral Diseases) 07/2015 - 11/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022

Drug/Important Bio-Agent (IBA)

65	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2010
31	entecavir FDA Link 01/2022 - 01/2011
24	Tenofovir (Viread)FDA Link 01/2022 - 09/2014
21	Alanine Transaminase (SGPT)IBA 01/2022 - 03/2009
17	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2010
15	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 01/2013
15	Serum AlbuminIBA 01/2022 - 03/2015
13	Hepatitis B e AntigensIBA 01/2022 - 01/2008
13	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021 - 01/2012
12	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 06/2012
11	BilirubinIBA 11/2021 - 07/2009
10	acarboxyprothrombin (PIVKA)IBA 01/2021 - 01/2012
10	Lamivudine (Epivir)FDA Link 01/2017 - 01/2008
8	Biomarkers (Surrogate Marker)IBA 10/2022 - 06/2012
8	Pharmaceutical PreparationsIBA 06/2021 - 07/2009
7	AlbuminsIBA 11/2021 - 03/2017
7	Fetal Proteins (Fetoprotein)IBA 01/2020 - 07/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
5	Transaminases (Aminotransferases)IBA 04/2021 - 07/2009
5	Prothrombin (Factor II)IBA 09/2019 - 01/2012
5	lipoarabinomannan (LAM)IBA 01/2017 - 09/2012
5	adefovirIBA 01/2017 - 01/2013
4	tenofovir alafenamideIBA 01/2022 - 10/2021
4	InterferonsIBA 11/2020 - 01/2013
4	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 07/2012
3	Aspartic Acid (Aspartate)FDA Link 01/2022 - 03/2009
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2021 - 01/2013
3	CholesterolIBA 11/2021 - 01/2020
3	Ribavirin (Virazole)FDA LinkGeneric 11/2020 - 02/2015
3	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 07/2016
3	wisteria lectinIBA 01/2020 - 01/2016
3	Carrier Proteins (Binding Protein)IBA 01/2020 - 01/2016
3	Vitamin K FDA Link 09/2019 - 07/2012
3	EnzymesIBA 01/2019 - 07/2016
3	RNA (Ribonucleic Acid)IBA 05/2018 - 02/2015
3	Transcription Factors (Transcription Factor)IBA 07/2016 - 11/2002
2	CalciumIBA 10/2022 - 01/2022
2	lenvatinibIBA 03/2022 - 05/2021
2	AntigensIBA 01/2022 - 09/2016
2	Indicators and Reagents (Reagents)IBA 10/2021 - 01/2017
2	C-PeptideIBA 06/2021 - 07/2016
2	Protons (Proton)IBA 01/2021 - 06/2019
2	CreatinineIBA 01/2020 - 03/2017
2	NucleosidesIBA 01/2018 - 01/2016
2	thiamine triphosphorate (TTP)IBA 01/2018 - 02/2017
2	DiureticsIBA 11/2017 - 01/2016
2	C-Reactive ProteinIBA 03/2017 - 01/2014
2	ORALIT (ORS)IBA 01/2017 - 08/2015
2	Interleukin-8 (Interleukin 8)IBA 01/2016 - 04/2014
2	Telbivudine FDA Link 11/2015 - 01/2013
2	AntioxidantsIBA 01/2015 - 04/2005
2	Small Interfering RNA (siRNA)IBA 04/2014 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2013 - 01/2011

Therapy/Procedure

61	Therapeutics 03/2022 - 02/2008
9	Drug Therapy (Chemotherapy) 10/2021 - 12/2008
6	Chemoradiotherapy 05/2022 - 10/2014
5	Liver Transplantation 09/2020 - 01/2013
5	Radiotherapy 01/2020 - 12/2010
4	Radiofrequency Ablation 09/2020 - 01/2015
4	Transplantation 01/2013 - 10/2003
3	Hepatectomy 06/2019 - 04/2011
2	Fontan Procedure (Fontan Operation) 10/2022 - 10/2014
2	Conservative Treatment 01/2020 - 11/2013
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2017 - 02/2015